Reverse Moore's Law: drug discovery gets more expensive every year. On the Oxford Biotech Podcast we talk to Professor Chas Bountra, former head of biology at GSK, about the new open-source solution he is developing to bring down the costs of lead development.

Music from: <a href='https://freesound.org/'>https://freesound.org/</a>

Reverse Moore's Law: drug discovery gets more expensive every year. On the Oxford Biotech Podcast we talk to Professor Chas Bountra, former head of biology at GSK, about the new open-source solution he is developing to bring down the costs of lead development. Music from: https://freesound.org/

Reverse Moore's Law: drug discovery gets more expensive every year. On the Oxford Biotech Podcast we talk to Professor Chas Bountra, former head of biology at GSK, about the new open-source solution he is developing to bring down the costs of lead development.

Music from:&nbsp;<a href="https://freesound.org/" rel="noopener noreferrer">https://freesound.org/</a>

Why Drug Discovery Is Getting More Expensive And How To Fix It With Structural Genomics Consortium Chief Scientist Chas Bountra

Informative and fun interviews with technology and business thought leaders in Biotech.

Share Why Drug Discovery Is Getting More Expensive And How To Fix It With Structural Genomics Consortium Chief Scientist Chas Bountra

Sign up to save your podcasts

Why Drug Discovery Is Getting More Expensive And How To Fix It With Structural Genomics Consortium Chief Scientist Chas Bountra

Why Drug Discovery Is Getting More Expensive And How To Fix It With Structural Genomics Consortium Chief Scientist Chas Bountra